Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Blood Pressure Monitoring Devices Market, By Product

7.1. Blood Pressure Monitoring Devices Market, by Product Type, 2022-2030
7.1.1. Digital Blood Pressure Monitor (Wrist, Arm, Finger)
7.1.1.1. Market Revenue and Forecast (2021-2030)
7.1.2. Sphygmomanometer
7.1.2.1. Market Revenue and Forecast (2021-2030)
7.1.3. Ambulatory Blood Pressure Monitor
7.1.3.1. Market Revenue and Forecast (2021-2030)
7.1.4. Instruments & Accessories
7.1.4.1. Market Revenue and Forecast (2021-2030)
7.1.5. Transducers

Chapter 8. Global Blood Pressure Monitoring Devices Market, By End-Use

8.1. Blood Pressure Monitoring Devices Market, by End-Use, 2022-2030
8.1.1. Ambulatory Surgical Centers & Clinics
8.1.1.1. Market Revenue and Forecast (2021-2030)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2021-2030)
8.1.3. Home Healthcare
8.1.3.1. Market Revenue and Forecast (2021-2030)

Chapter 9. Global Blood Pressure Monitoring Devices Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2021-2030)
9.1.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2021-2030)
9.1.3.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2021-2030)
9.1.4.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2021-2030)
9.2.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2021-2030)
9.2.3.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2021-2030)
9.2.4.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2021-2030)
9.2.5.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2021-2030)
9.2.6.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2021-2030)
9.3.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2021-2030)
9.3.3.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2021-2030)
9.3.4.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2021-2030)
9.3.5.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2021-2030)
9.3.6.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2021-2030)
9.4.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2021-2030)
9.4.3.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2021-2030)
9.4.4.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2021-2030)
9.4.5.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2021-2030)
9.4.6.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2021-2030)
9.5.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2021-2030)
9.5.3.2. Market Revenue and Forecast, by End-Use (2021-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2021-2030)
9.5.4.2. Market Revenue and Forecast, by End-Use (2021-2030)

Chapter 10. Company Profiles

10.1. Koninklijke Philips N.V.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. General Electric Company
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. A & D Company, Limited
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. SunTech Medical, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Welch Allyn
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. American Diagnostic Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Briggs Healthcare
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Withings
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Spacelabs Healthcare
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. GF HEALTH PRODUCTS, INC.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Kaz, A Helen of Troy Company
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Rossmax International Limited
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. Microlife Corporation
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms